Title: Prolonged and tunable residence time using reversible covalent kinase inhibitors.
Journal: Nature chemical biology 20150701
Title: Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.
Journal: Nature chemical biology 20081101
Title: Somana Siva Prasad, et al. A QUALITY BY DESIGN APPROACH FOR DEVELOPMENT OF SIMPLE AND ROBUST REVERSED PHASE STABILITY INDICATING HPLC METHOD FOR ESTIMATION OF IBRUTINIB AND ITS IMPURITIES.
Title: Honigberg LA, et al. The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci U S A. 2010 Jul 20;107(29):13075-80.